Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 18/20 | 0.42 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6858746 | 1.00 | ADORA2B (0.42) | ADORA2BPOLBMEN1KMT2AL3MBTL1 | |
| SCHEMBL6858742 | 1.00 | ADORA2B (0.42) | ADORA2BPOLBMEN1KMT2AL3MBTL1 | |
| SCHEMBL6861590 | 0.88 | ADORA2B (0.48) | ADORA2BPOLBL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL6861594 | 0.88 | ADORA2B (0.48) | ADORA2BPOLBL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL6861588 | 0.88 | ADORA2B (0.48) | ADORA2BPOLBL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL6860179 | 0.87 | ADORA2B (0.46) | ADORA2BPOLBMEN1KMT2AL3MBTL1 | |
| SCHEMBL6860176 | 0.87 | ADORA2B (0.46) | ADORA2BPOLBMEN1KMT2AL3MBTL1 | |
| SCHEMBL6860172 | 0.87 | ADORA2B (0.46) | ADORA2BPOLBMEN1KMT2AL3MBTL1 | |
| SCHEMBL6860249 | 0.87 | ADORA2B (0.38) | ADORA2BPOLBL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL6860259 | 0.87 | ADORA2B (0.38) | ADORA2BPOLBL3MBTL1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6794523-B2 | ANTICANCER AGENTS, ANTITUMOR AGENTS; LEUKEMIA | FLORIDA STATE UNIVERSITY | 2004-09-21 | — | — | US | disclosed |
| US-20030065200-A1 | Anticancer agents, antitumor agents; leukemia | FLORIDA STATE UNIVERSITY | 2003-04-03 | — | — | US | disclosed |
| US-6455575-B2 | ANTITUMOR AGENTS | BRISTOL-MYERS SQUIBB COMPANY | 2002-09-24 | — | — | US | disclosed |
| EP-0639577-B1 | Phosphonooxymethyl or methylthiomethyl ethers of taxane derivatives as antitumor agents | BRISTOL MYERS SQUIBB CO (US) | 2002-05-15 | — | — | EP | disclosed |
| EP-0590267-B1 | Deoxy taxols | BRISTOL MYERS SQUIBB CO (US) | 2002-05-08 | — | — | EP | disclosed |
| EP-0694539-B1 | 7-O-Ethers of taxane derivatives | BRISTOL MYERS SQUIBB CO (US) | 2001-11-28 | — | — | EP | disclosed |
| US-20010023255-A1 | PHOSPHONOOXYMETHYL ETHERS OF TAXANE DERIVATIVES | GOLIK JERZY (US) | 2001-09-20 | — | — | US | disclosed |
| US-6201140-B1 | ANTITUMOR AGENTS | BRISTOL-MYERS SQUIBB COMPANY | 2001-03-13 | — | — | US | disclosed |
| US-6018073-A | Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them | FLORIDA STATE UNIVERSITY (US) | 2000-01-25 | — | — | US | disclosed |
| US-5739362-A | ANTILEUKEMIA, ANTITUMOR AGENTS | FLORIDA STATE UNIVERSITY (US) | 1998-04-14 | — | — | US | disclosed |
| US-5646176-A | Phosphonooxymethyl ethers of taxane derivatives | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-07-08 | — | — | US | disclosed |
| EP-0694539-A1 | 7-o-Ethers of taxane derivatives | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-01-31 | — | — | EP | disclosed |
| US-5478854-A | Antitumor agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-12-26 | — | — | US | disclosed |
| EP-0639577-A1 | Phosphonooxymethyl or methylthiomethyl ethers of taxane derivatives as antitumor agents | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065200-A1 | Anticancer agents, antitumor agents; leukemia | MCL1, BCL3, TOP2A | ADORA2B 4197/4885POLB 928/4885MEN1 2533/4885 |
| US-20010023255-A1 | PHOSPHONOOXYMETHYL ETHERS OF TAXANE DERIVATIVES | PHOSPHO1, MTMR1, PIK3CA | ADORA2B 3021/4885POLB 1035/4885MEN1 2172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.